There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Angie Drakulich was editorial director of Pharmaceutical Technology.

Articles

The US Food and Drug Administration will hold a public hearing Oct. 2, 2008, to obtain input regarding over-the-counter (OTC) cough and cold drugs marketed for pediatric use.

Public Comment on Cough and Cold Meds for Kids

The deadline for nominations for the Innovations in Pharma Science Awards is here. Check out http://pharmtech.com/Innovations to nominate your company's work in one of five areas by next week

Time is Running out for Innovation Awards

Also, Shire recalls "Daytrana" patch, Chromatide forms Scientific Advisory Board, more...

Company and People Notes: Gilead Sciences to Expand Headquarters and add 1900 Jobs, WuXi Appoints Rujian Ma as VP of Synthetic Chemistry, More

The US Pharmacopeial Conventional added to its international sites with the official opening of its facility in Sao Paulo, Brazil.

USP Opens Site in Brazil

Also, Tekmira will collaborate with Bristol-Myers Squibb, Helicos Biosciences appoints Steve Lombardi CEO, more...

Company and People Notes: CSL to Acquire Talecris, Benda Appoints George Zhou COO, More...

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Actavis Totowa LLC, the US subsidiary of the generic drug manufacturer Actavis Group, is announcing a voluntary recall to the retail level of all drug products manufactured at its Little Falls, New Jersey, facility. This is a precautionary, voluntary action by Actavis following an inspection conducted by the Food and Drug Administration earlier this year.

Actavis Voluntary Recalls Products for GMP Violations

The US Food and Drug Administration has distributed a draft of Guidance for Industry: Residual Solvents in Drug Products Marketed in the United States for public comment.

FDA Releases Draft Guidance on Residual Solvents

Also, Ortho Biotech recalls one lot of "Procrit" due to cracked vials, more appointments at Actavis, more...

Company and People Notes: Genentech Rejects Roche's Bid, TorreyPines CEO Retires, More...

Also, Bilcare Global Clinical Supplies opens new headquarters in San Francisco, Sigurdur Oli Olafsson named CEO of Actavis Group, more...

Company and People Notes: Meda will Acquire Valeant's Western and Eastern European Businesses, Catalent Names George L. Fotiades Interim President and CEO, More...

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Legislative decisions to increase Medicare's formulary may lead to a fight over drug approvals.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes